|
Volumn 73, Issue 6, 2012, Pages 878-883
|
Developing and delivering clinical toxicology in the UK National Health Service
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLCYSTEINE;
ACETYLSALICYLIC ACID;
ACTIVATED CARBON;
ANTIDEPRESSANT AGENT;
ANTIDOTE;
CITALOPRAM;
COCODAMOL;
CODEINE;
DIAMORPHINE;
DIAZEPAM;
DICLOFENAC;
FLUOXETINE;
HERBICIDE;
IBUPROFEN;
LIPID EMULSION;
LOCAL ANESTHETIC AGENT;
METHADONE;
MORPHINE;
PARACETAMOL;
PESTICIDE;
SEDATIVE AGENT;
ZOPICLONE;
ACCREDITATION;
CLINICAL PHARMACOLOGY;
CLINICAL TOXICOLOGY;
CLINICAL TRIAL (TOPIC);
COST EFFECTIVENESS ANALYSIS;
CURRICULUM;
DRUG FATALITY;
DRUG INTOXICATION;
DRUG OVERDOSE;
DRUG SURVEILLANCE PROGRAM;
DRUG TOLERABILITY;
EDUCATION PROGRAM;
EVIDENCE BASED MEDICINE;
HEALTH CARE DELIVERY;
HEALTH CARE ORGANIZATION;
HEALTH PROGRAM;
HUMAN;
LEADERSHIP;
LENGTH OF STAY;
LIVER TOXICITY;
MEDICAL EDUCATION;
MEDICAL SPECIALIST;
NATIONAL HEALTH SERVICE;
NOTE;
OPTIMAL DRUG DOSE;
PRIORITY JOURNAL;
PUBLIC HEALTH;
RISK BENEFIT ANALYSIS;
STOMACH LAVAGE;
TOXICOLOGY;
UNITED KINGDOM;
GREAT BRITAIN;
HUMANS;
NATIONAL HEALTH PROGRAMS;
PHARMACEUTICAL PREPARATIONS;
PHARMACOLOGY, CLINICAL;
TOXICOLOGY;
|
EID: 84860698770
PISSN: 03065251
EISSN: 13652125
Source Type: Journal
DOI: 10.1111/j.1365-2125.2012.04229.x Document Type: Note |
Times cited : (6)
|
References (11)
|